Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Andrea Papadia

9PUBLICATIONS

15CO-AUTHORS

Predictive and prognostic markersCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer diagnosis

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (9)

Sort by Publication Date:

|Jul 26, 2022

The added value of SLN mapping with indocyanine green in low- and intermediate-risk endometrial cancer management: a systematic review and meta-analysis.

Lara C Burg, Shenna Verheijen, Ruud L M Bekkers

|Dec 14, 2021

Cytologic presentation of ovarian large cell carcinoma with rhabdoid features detected on peritoneal washing. Report of one case with cyto-histologic correlation and previously undescribed inactivating SMARCA-4 mutations.

Franco Fulciniti, Jessica Barizzi, Paola Migliora

|Nov 30, 2019

Minimally invasive surgery does not impair overall survival in stage IIIC endometrial cancer patients.

Andrea Papadia, Alicia Garbade, Maria Luisa Gasparri

|Sep 10, 2018

Correction to: The impact of different doses of indocyanine green on the sentinel lymph-node mapping in early stage endometrial cancer.

Andrea Papadia, Alessandro Buda, Maria Luisa Gasparri

|Jul 26, 2018

The impact of different doses of indocyanine green on the sentinel lymph-node mapping in early stage endometrial cancer.

Andrea Papadia, Alessandro Buda, Maria Luisa Gasparri

|Apr 26, 2018

Retrospective validation of the laparoscopic ICG SLN mapping in patients with grade 3 endometrial cancer.

Andrea Papadia, Maria Luisa Gasparri, Anda P Radan

Pageof 2

Frequent Collaborators

1 joint publications

Franco Fulciniti

1 joint publications

Lara C Burg

1 joint publications

Shenna Verheijen

1 joint publications

Ruud L M Bekkers

1 joint publications

Joanna IntHout

1 joint publications

Robert W Holloway

1 joint publications

Salih Taskin

1 joint publications

Sarah E Ferguson

1 joint publications

Yu Xue

1 joint publications

Antonino Ditto

Frequent Collaborators

1 joint publications

Franco Fulciniti

1 joint publications

Lara C Burg

1 joint publications

Shenna Verheijen

1 joint publications

Ruud L M Bekkers

Top Related Videos

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on : Aug 19, 2021

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on : Sep 12, 2019

See more related videos

Top Related Videos

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on : Aug 19, 2021

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on : Sep 12, 2019

See more related videos